Hyderabad-based SCIINV Biosciences has identified a new AI-driven repurposed antibiotic now entering human clinical trials. The breakthrough, backed by Whale Tank Biocatalyst, reduces development time and offers hope in combating antimicrobial resistance amid a stagnating global antibiotic pipeline.
Hyderabad-based SCIINV Biosciences partnered with UK’s Microbira Ltd to develop advanced digital diagnostics targeting antimicrobial resistance. Their joint innovation aims to ensure early pathogen detection, reducing antibiotic misuse and improving healthcare outcomes in India and globally
ASPIRE BioNEST incubated startup SCIINV Biosciences AI/ML digital diagnostic platform AMRx at the University of Hyderabad (UoH) has been included in the Coffee Table Book which lists the top 200 AI first movers who are leveraging the power of AI to transform their businesses
The partnership strengthens the ties between UK and India while addressing one of the most urgent global health challenges—antimicrobial resistance (AMR)
